Skip to content

Clinical trials

Recruiting Inflammatory Bowel Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Status: Recruiting Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20211
20221
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Universität Duisburg-Essen2
Alexandra Miriam Kiess1
Janssen-Cilag G.m.b.H1
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1
Spyre Therapeutics, Inc.1
University Hospital Tuebingen1
University of Giessen1
University of Ulm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases11
Colitis, Ulcerative7
Crohn Disease7
Chronic Disease1
Colitis1
Colonic Diseases1
Digestive System Diseases1
Gastroenteritis1
Gastrointestinal Diseases1
Heart Defects, Congenital1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.